Your browser doesn't support javascript.
loading
Successful management of tumor necrosis factor-α inhibitor-induced erythema multiforme by switching to a Janus kinase inhibitor in a patient with rheumatoid arthritis and ulcerative colitis.
Takeuchi, Sakiko; Fukuda, Keitaro; Tanaka, Ryo; Funakoshi, Takeru; Takahashi, Hayato; Amagai, Masayuki; Tanikawa, Akiko.
Afiliación
  • Takeuchi S; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Fukuda K; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Tanaka R; Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Funakoshi T; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Takahashi H; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Amagai M; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Tanikawa A; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
J Dermatol ; 50(4): e117-e118, 2023 04.
Article en En | MEDLINE | ID: mdl-36412225

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / Colitis Ulcerosa / Eritema Multiforme / Inhibidores de las Cinasas Janus Límite: Humans Idioma: En Revista: J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / Colitis Ulcerosa / Eritema Multiforme / Inhibidores de las Cinasas Janus Límite: Humans Idioma: En Revista: J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Japón